DSM-5 睡眠障碍模块结构性临床访谈的可靠性。
Reliability of the Structured Clinical Interview for DSM-5 Sleep Disorders Module.
机构信息
Department of Psychology, The University of North Texas, Denton, Texas.
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.
出版信息
J Clin Sleep Med. 2018 Mar 15;14(3):459-464. doi: 10.5664/jcsm.7000.
STUDY OBJECTIVES
To develop and demonstrate interrater reliability for a Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Sleep Disorders (SCISD).
METHODS
The SCISD was designed to be a brief, reliable, and valid interview assessment of adult sleep disorders as defined by the DSM-5. A sample of 106 postdeployment active-duty military members seeking cognitive behavioral therapy for insomnia in a randomized clinical trial were assessed with the SCISD prior to treatment to determine eligibility. Audio recordings of these interviews were double-scored for interrater reliability.
RESULTS
The interview is 8 pages long, includes 20 to 51 questions, and takes 10 to 20 minutes to administer. Of the nine major disorders included in the SCISD, six had prevalence rates high enough (ie, n ≥ 5) to include in analyses. Cohen kappa coefficient (κ) was used to assess interrater reliability for insomnia, hypersomnolence, obstructive sleep apnea hypopnea (OSAH), circadian rhythm sleep-wake, nightmare, and restless legs syndrome disorders. There was excellent interrater reliability for insomnia (1.0) and restless legs syndrome (0.83); very good reliability for nightmare disorder (0.78) and OSAH (0.73); and good reliability for hypersomnolence (0.50) and circadian rhythm sleep-wake disorders (0.50).
CONCLUSIONS
The SCISD is a brief, structured clinical interview that is easy for clinicians to learn and use. The SCISD showed moderate to excellent interrater reliability for six of the major sleep disorders in the DSM-5 among active duty military seeking cognitive behavioral therapy for insomnia in a randomized clinical trial. Replication and extension studies are needed.
CLINICAL TRIAL REGISTRATION
Registry: ClinicalTrials.gov; Title: Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia; Identifier: NCT01549899; URL: https://clinicaltrials.gov/ct2/show/NCT01549899.
研究目的
开发并验证用于诊断和统计手册第五版（DSM-5）睡眠障碍的结构化临床访谈（SCISD）的评分者间信度。
方法
SCISD 旨在成为一种简短、可靠且有效的成人睡眠障碍访谈评估方法，该评估方法根据 DSM-5 进行定义。一项针对随机临床试验中寻求失眠认知行为治疗的 106 名部署后现役军人的样本在治疗前使用 SCISD 进行评估，以确定其是否符合资格。这些访谈的音频记录被双评分以评估评分者间信度。
结果
该访谈共有 8 页，包含 20 到 51 个问题，需要 10 到 20 分钟完成。在 SCISD 中包含的九个主要障碍中，有六个障碍的患病率足够高（即，n≥5），可以包括在分析中。使用 Cohen kappa 系数（κ）评估失眠、嗜睡症、阻塞性睡眠呼吸暂停低通气（OSAH）、昼夜节律睡眠-觉醒、噩梦和不宁腿综合征障碍的评分者间信度。失眠（1.0）和不宁腿综合征（0.83）的评分者间信度极好；噩梦障碍（0.78）和 OSAH（0.73）的信度非常好；嗜睡症（0.50）和昼夜节律睡眠-觉醒障碍（0.50）的信度良好。
结论
SCISD 是一种简短的结构化临床访谈，易于临床医生学习和使用。在一项随机临床试验中，SCISD 显示出在 DSM-5 中的六种主要睡眠障碍中具有中度至极好的评分者间信度，这些障碍是现役军人寻求失眠认知行为治疗的原因。需要进一步的复制和扩展研究。
临床试验注册
注册机构：ClinicalTrials.gov；标题：比较互联网和现场简短认知行为治疗失眠；标识符：NCT01549899；网址：https://clinicaltrials.gov/ct2/show/NCT01549899。
Zotero 插件